• Quem Somos / Who we are?

    A luta contra o cancro é um trabalho diário e permanente, que requer um esforço de pesquisa e reinvenção constantes na busca por novos tratamentos, novos métodos e esperanças renovadas. Este trabalho não é possível sem as pessoas certas para o desenvolver. Por isso, apresentamos as principais valências do IPO Porto ao nível do Ensino e Investigação – duas premissas que consideramos que devem andar de mãos dadas.

    The fight against cancer is a daily and ongoing effort, requiring constant research and reinvention in the pursuit of new treatments, new methods, and renewed hope. This work is only possible with the right people to carry it forward. That is why we present the main strengths of IPO Porto in the fields of Education and Research – two principles that we believe must go hand in hand.

Anúncios do site

Ainda não existem tópicos de discussão neste fórum

Disciplinas disponíveis

Africa Connect Project: African Initiative Against Oesophageal Cancer

Oesophageal Squamous Cell Carcinoma (OSCC) is one of the main subtypes of oesophageal cancer, accounting for more than 85% of worldwide OC diagnoses and is the most common subtype in low-and middle-income countries, including Sub-Saharan Africa.

Developed under the Africa Connect Project: African Initiative Against Oesophageal Cancer (AFROC), this blended-learning course was designed to empower gastroenterologists and surgical endoscopists across Africa to improve the detection rate and treatment outcomes of OSCC. By doing so, it aims to contribute meaningfully to more equitable access to healthcare, as well as improved survival outcomes and quality of life for OSCC patients.

The course includes job shadowing and on-the-job training for a selected group of invited participants in leadership roles, alongside a webinar series open to a broader community of African endoscopists. Bringing together leading global experts in the field, this course offers a unique opportunity to access the latest evidence-based knowledge, share experiences, and discuss real-world challenges in OSCC care.